Share
Copy Link
Link copied
Trials Examine Use of High-Dose Aflibercept for 12- and 16-Week Dosing for Wet AMD and DME
Show Description +
Share
Copy Link
Link copied
Trials Examine Use of High-Dose Aflibercept for 12- and 16-Week Dosing for Wet AMD and DME
Posted: 9/14/2022
AMD, Age-Related Macular Degeneration (AMD), Diabetic macular edema, DME, DME, aflibercept, Clinical Trials
Please log in to leave a comment.